Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$26.05 - $37.48 $108,915 - $156,703
4,181 New
4,181 $119 Million
Q1 2022

May 16, 2022

SELL
$24.46 - $40.92 $11,276 - $18,864
-461 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$35.0 - $45.94 $16,135 - $21,178
461 New
461 $19 Million
Q3 2021

Nov 15, 2021

SELL
$36.8 - $60.62 $174,505 - $287,460
-4,742 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$32.46 - $45.0 $153,925 - $213,390
4,742 New
4,742 $198 Million

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $919M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Alpha Paradigm Partners, LLC Portfolio

Follow Alpha Paradigm Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Paradigm Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Paradigm Partners, LLC with notifications on news.